These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 32332073)

  • 1. The microbiome in rheumatology: Where are we and where should we go?
    Manasson J; Blank RB; Scher JU
    Ann Rheum Dis; 2020 Jun; 79(6):727-733. PubMed ID: 32332073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulatory interplay of the microbiome and therapy of rheumatic diseases.
    Ostrov BE; Amsterdam D
    Immunol Invest; 2017 Nov; 46(8):769-792. PubMed ID: 29058546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human microbiome in rheumatic autoimmune diseases: A comprehensive review.
    Coit P; Sawalha AH
    Clin Immunol; 2016 Sep; 170():70-9. PubMed ID: 27493014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbiome dynamics in rheumatic diseases.
    Wang Y; Wang Z; Lu Q
    Curr Opin Rheumatol; 2024 Mar; 36(2):134-141. PubMed ID: 37976078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The microbiome in autoimmune rheumatic disease.
    Konig MF
    Best Pract Res Clin Rheumatol; 2020 Feb; 34(1):101473. PubMed ID: 32044247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mini-Review: Human Microbiome and Rheumatic Diseases.
    Vural M; Gilbert B; Üstün I; Caglar S; Finckh A
    Front Cell Infect Microbiol; 2020; 10():491160. PubMed ID: 33304855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metabolic role of the gut microbiota in health and rheumatic disease: mechanisms and interventions.
    Abdollahi-Roodsaz S; Abramson SB; Scher JU
    Nat Rev Rheumatol; 2016 Aug; 12(8):446-55. PubMed ID: 27256713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The microbiome and autoimmunity].
    Schröder T; Ibrahim S
    Internist (Berl); 2017 May; 58(5):449-455. PubMed ID: 28321459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the Microbiome on the Immune System.
    Lambring CB; Siraj S; Patel K; Sankpal UT; Mathew S; Basha R
    Crit Rev Immunol; 2019; 39(5):313-328. PubMed ID: 32422014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immuno-ecology: how the microbiome regulates tolerance and autoimmunity.
    Paun A; Danska JS
    Curr Opin Immunol; 2015 Dec; 37():34-9. PubMed ID: 26460968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Microbiome: a Revolution in Treatment for Rheumatic Diseases?
    Rosenbaum JT; Asquith MJ
    Curr Rheumatol Rep; 2016 Oct; 18(10):62. PubMed ID: 27641915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiota and metabolites in rheumatic diseases.
    Tong Y; Marion T; Schett G; Luo Y; Liu Y
    Autoimmun Rev; 2020 Aug; 19(8):102530. PubMed ID: 32240855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmunity in microbiome-mediated diseases and novel therapeutic approaches.
    Shin C; Kim YK
    Curr Opin Pharmacol; 2019 Dec; 49():34-42. PubMed ID: 31129556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The infectious origin of autoimmune diseases: new concepts to understand the pathogenesis of rheumatic diseases.
    Zepp F
    Rev Rhum Engl Ed; 1997 Oct; 64(10 Suppl):153S-155S. PubMed ID: 9385667
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of the intestinal microbiome in autoimmune diseases and its use in treatments.
    Marietta E; Horwath I; Balakrishnan B; Taneja V
    Cell Immunol; 2019 May; 339():50-58. PubMed ID: 30366573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pneumococcal antibody protection in patients with autoimmune inflammatory rheumatic diseases with varying vaccination status.
    Rasmussen SL; Fuursted K; Nielsen KA; Laurberg NP; Sørensen MB; Fagerberg SK; Leutscher P; Rasmussen C
    Scand J Rheumatol; 2020 Sep; 49(5):353-360. PubMed ID: 32468899
    [No Abstract]   [Full Text] [Related]  

  • 17. Microbiome Regulation of Autoimmune, Gut and Liver Associated Diseases.
    Singh B; Qin N; Reid G
    Inflamm Allergy Drug Targets; 2015; 14(2):84-93. PubMed ID: 26817477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human genome-microbiome interaction: metagenomics frontiers for the aetiopathology of autoimmune diseases.
    Gundogdu A; Nalbantoglu U
    Microb Genom; 2017 Apr; 3(4):e000112. PubMed ID: 28785422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From hype to hope: Considerations in conducting robust microbiome science.
    McGuinness AJ; Stinson LF; Snelson M; Loughman A; Stringer A; Hannan AJ; Cowan CSM; Jama HA; Caparros-Martin JA; West ML; Wardill HR;
    Brain Behav Immun; 2024 Jan; 115():120-130. PubMed ID: 37806533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Klebsiella pneumoniae pneumonia in patients with rheumatic autoimmune diseases: clinical characteristics, antimicrobial resistance and factors associated with extended-spectrum β-lactamase production.
    Liu Y; Liu Y; Dai J; Liu A; Li Y; Xu J; Yu X; Liu J; Zhu H
    BMC Infect Dis; 2021 Apr; 21(1):366. PubMed ID: 33865323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.